NCT01718535View on ClinicalTrials.gov

Method Comparison Study of the Spartan FRX CYP2C19 Genotyping System Against Bi-directional Sequencing

CompletedOBSERVATIONAL
Enrollment

327

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

December 31, 2012

Conditions
Genotyping Techniques
Interventions
DEVICE

Spartan FRX CYP2C19 Test System

Trial Locations (1)

M5G1Z5

Mount Sinai Services, Toronto

All Listed Sponsors
collaborator

Mount Sinai Hospital, Canada

OTHER

lead

Spartan Bioscience Inc.

INDUSTRY

NCT01718535 - Method Comparison Study of the Spartan FRX CYP2C19 Genotyping System Against Bi-directional Sequencing | Biotech Hunter | Biotech Hunter